Literature DB >> 19818294

Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes.

Navdha Ramchurn1, Chiedza Mashamba, Elizabeth Leitch, Vijayaraman Arutchelvam, Kilimangalam Narayanan, Jola Weaver, Jennifer Hamilton, Carol Heycock, Vadivelu Saravanan, Clive Kelly.   

Abstract

INTRODUCTION: An increased prevalence of musculoskeletal disease is recognised in diabetes and is a common source of disability. It is known to predominantly affect the upper limbs especially the hand and shoulder. The relationship with other complications of diabetes and glycaemic control is uncertain. We designed this study to clarify these relationships, and to assess differences between types 1 and 2 diabetes.
METHODS: We identified a group of 96 people with established diabetes and examined them for the presence of locomotor disease focussing on the upper limbs. We recorded the mean HbA1c and the presence of diabetic complications, together with the health assessment questionnaire (HAQ) score. We explored correlations between locomotor disease and these variables using logistic regression. We compared data between type 1 and type 2 diabetics and contrasted the amalgamated data with that of a matched control population of medical out patients using Students t tests.
RESULTS: Locomotor disease was present in 75% of diabetics with the upper limb the commonest site for abnormalities. This prevalence was significantly higher than that seen in the controls (53%) [p=0.02]. Shoulder capsulitis (25%), carpal tunnel syndrome (20%), tenosynovitis (29%), limited joint mobility (28%) and Dupuytrens contracture (13%) were the most frequent findings and were much commoner than in controls. Capsulitis usually coexisted with other upper limb abnormalities and best predicted the presence of retinopathy and/or neuropathy. The mean HbA1c was significantly higher in patients with combined shoulder and hand problems (9.1%) than in those with no upper limb problems (8.0%) [p=0.018]. The pattern of results was similar in type 1 and type 2 diabetes, although the prevalence of abnormalities and mean HAQ were significantly greater in type 2 patients, which may be in part a function of their greater mean age.
CONCLUSION: Upper limb locomotor abnormalities are very common in diabetes and are associated with worse glycaemic control and more diabetic complications. Assessment of upper limb locomotor disease in diabetes should include an estimate of glycaemic control and a search for other complications.

Entities:  

Mesh:

Year:  2009        PMID: 19818294     DOI: 10.1016/j.ejim.2009.08.001

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  40 in total

1.  Mid-portion Achilles tendinopathy: why painful? An evidence-based philosophy.

Authors:  Lucy Blackbourn; Angelo Del Buono; Nicola Maffulli
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-09-25       Impact factor: 4.342

2.  Effect of low-level laser therapy on healing of tenotomized Achilles tendon in streptozotocin-induced diabetic rats.

Authors:  Mohsen Nouruzian; Morteza Alidoust; Mohammad Bayat; Mehernoush Bayat; Mohammad Akbari
Journal:  Lasers Med Sci       Date:  2012-02-28       Impact factor: 3.161

3.  An overlooked rheumatologic manifestation of diabetes: diabetic cheiroarthropathy.

Authors:  Neslihan Gokcen; Seher Cetinkaya Altuntas; Ilke Coskun Benlidayi; Murat Sert; Ersin Nazlican; Tunay Sarpel
Journal:  Clin Rheumatol       Date:  2019-02-02       Impact factor: 2.980

4.  Relationship Between Skin Intrinsic Fluorescence--an Indicator of Advanced Glycation End Products-and Upper Extremity Impairments in Individuals With Diabetes Mellitus.

Authors:  Kshamata M Shah; B Ruth Clark; Janet B McGill; Catherine E Lang; John Maynard; Michael J Mueller
Journal:  Phys Ther       Date:  2015-04-09

5.  Articular and abarticular manifestations in type 2 diabetes mellitus.

Authors:  Fatima Ezzahra Abourazzak; Nessrine Akasbi; Ghita Sqalli Houssaini; Sabah Bazouti; Salma Bensbaa; Hicham Hachimi; Farida Ajdi; Taoufik Harzy
Journal:  Eur J Rheumatol       Date:  2014-12-01

Review 6.  Alterations of tendons in diabetes mellitus: what are the current findings?

Authors:  Liu Shi; Yun-Feng Rui; Gang Li; Chen Wang
Journal:  Int Orthop       Date:  2015-05-06       Impact factor: 3.075

7.  Upper extremity impairments, pain and disability in patients with diabetes mellitus.

Authors:  K M Shah; B R Clark; J B McGill; M J Mueller
Journal:  Physiotherapy       Date:  2014-09-19       Impact factor: 3.358

Review 8.  Neuronal regulation of tendon homoeostasis.

Authors:  Paul W Ackermann
Journal:  Int J Exp Pathol       Date:  2013-05-30       Impact factor: 1.925

9.  Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study.

Authors:  Wen-Hsuan Hou; Kai-Cheng Chang; Chung-Yi Li; Huang-Tz Ou
Journal:  Br J Clin Pharmacol       Date:  2018-06-29       Impact factor: 4.335

10.  O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.

Authors:  Xun Wang; Zhihui Feng; Xueqiang Wang; Liang Yang; Shujun Han; Ke Cao; Jie Xu; Lin Zhao; Yong Zhang; Jiankang Liu
Journal:  Diabetologia       Date:  2016-03-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.